Gout/Crystal
Date |
Type | Title | Save |
|---|---|---|---|
| 18 Mar 2019 | News | Ironwood Retreats from the US Gout Market | |
| 14 Mar 2019 | Social | QD44 - RA and Gout https://t.co/5a4rtwt1dw via @YouTube | |
| 14 Mar 2019 | ACR Video | QD Clinic - RA and Gout | |
| 06 Mar 2019 | Social | Pt with a history of gout. Acute onset of pain at 1st MTP joint. Ultrasound shows 1st MTP Synovitis. Synovial thickening with hypervascularity is noted on the dorsal aspect of 1st metatarsophalangeal joint. https://t.co/BH4C56Yerq | |
| 05 Mar 2019 | Social | An Internet survey of 320 physician-diagnosed #gout pts finds that 23% diagnosed as having a sleep disorder (sleep apnea, 17%). Their mean sleep time was 6.7 h per night; 86% reported snoring during sleep and 2/3 reported feeling sleepy during the day https://t.co/7DiuZOM1aw | |
| 28 Feb 2019 | News | Allopurinol Reduces Cardiovascular Outcomes in Diabetes | |
| 28 Feb 2019 | Social | FDA approval of an oral colchicine Gloperba for Adult Gout Flares - is this really an advance? At what price? You dont need colchicine to manage most cases of gout -my opinion of course! https://t.co/YnPl4Qchjj | |
| 25 Feb 2019 | Social | QD Clinic - New Changes to Gout Guidelines. Lessons from the clinic - a noncompliant gout patient needs to restart his gout drugs, what to do with febuxostat? https://t.co/XwaUewBjWS via @YouTube | |
| 25 Feb 2019 | ACR Video | QD Clinic - New Changes to Gout Guidelines | |
| 25 Feb 2019 | News | FDA Slaps a Boxed Warning on Febuxostat for CV Risk | |
| 22 Feb 2019 | Social | FDAhas added a boxed warning to the label for gout drug febuxostat (Uloric) based on results of a large postmarketing safety study and AAC panel Recs. FDA concluded that there is an increased risk for death with febuxostat compared allopurinol https://t.co/v1ANA3lI0g | |
| 13 Feb 2019 | Social | Genetic study using Mendelian randomization methods in a large UK biobank shows that whereas serum Uric acid has no association with eGFR level nor CKD risk, sUA does show a significant risk of #Gout. https://t.co/YRiVuOKof4 | |
| 29 Jan 2019 | Social | QD Clinic - The Tophi Guy | Gout case management from https://t.co/2dcFVgu8z6 https://t.co/Nj3PbgVuFK | |
| 29 Jan 2019 | ACR Video | QD Clinic - The Tophi Guy | |
| 25 Jan 2019 | Social | Using the 1998-2014 U.S. National Inpatient Sample- gout was associated with 9-20% higher healthcare utilization and 6% higher hazard of transfusion after primary hip replacement surgery. https://t.co/cSFnVJiX8s | |
| 21 Jan 2019 | News | U.S. Gout Rates Remain Steady, but Substantial | |
| 16 Jan 2019 | News | Febuxostat Gets Reprieve from FDA Advisory Panel | |
| 12 Jan 2019 | Social | RheumNow Podcast is up - discussing Gout FDA hearing, Gout Prevalence, ULT use, obesity, BMS-Celgene merger and more. Watch here https://t.co/J5xdqGYWAu Listen on iTunes or here> https://t.co/qHAO4E9cfX | |
| 11 Jan 2019 | News | Only One-Third of Gout Patients Receive Urate-Lowering Drugs | |
| 03 Jan 2019 | Social | Analysis of pegloticase clinical trial data shows that tophus resolution was achieved by 69.6% of 23 responders, 27.9% of 43 nonresponders, and 14.3% of 21 patients who received placebo. Resolution time = 9.9 mos. https://t.co/4Pu16t3BV8 |
